STOCK TITAN

Atrion Corporation Announces Election of New Director

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Atrion Corporation (NASDAQ: ATRI) announced the immediate election of Maria Sainz to its Board of Directors. With over 20 years in the medical device sector, Sainz has held CEO roles at successful medtech start-ups, two of which were acquired by major companies. Her experience includes leadership positions at Guidant Corporation and integration efforts post-acquisition by Boston Scientific. Additionally, she serves on the boards of public companies ShockWave Medical and Avanos Medical.

Positive
  • Maria Sainz brings over 20 years of relevant experience in medical devices.
  • Her leadership in successful start-ups indicates potential for innovative strategies.
  • Previous roles at Guidant Corporation may provide valuable industry insights.
Negative
  • Concerns may arise regarding continuity and governance experience.
  • Potential experience gap compared to long-serving board members.

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately.

Ms. Sainz brings to our Board over 20 years of medical device and management experience from both Silicon Valley start-ups and large medical device companies. During the period from 2008 until early this year, she served as the CEO of three innovative medtech start-ups. One of these companies was acquired by CooperSurgical in 2021 and another was acquired by Stryker Corporation in 2011. At Stryker, she led the Business Unit that comprised her former company. From 1998 to 2006, Ms. Sainz held a number of leadership positions at Guidant Corporation, including President of the Cardiac Surgery division, Vice President, Global Marketing for the Vascular Intervention division, and Vice President of the Intermedics Cardiac Rhythm Management business in Europe. From 2006 to 2008, Ms. Sainz led integration activities following the acquisition of Guidant by Boston Scientific.

Ms. Sainz serves as a director of two other public companies, ShockWave Medical (SWAV) and Avanos Medical (AVNS). We are proud to add Ms. Sainz to our Board.

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.

Contact:Jeffery Strickland
 Vice President and Chief Financial Officer
 (972) 390-9800


FAQ

Who is Maria Sainz in relation to ATRI?

Maria Sainz has been elected as a director of Atrion Corporation, bringing extensive experience from the medical device industry.

What experience does Maria Sainz have?

She has over 20 years of experience in medical devices, including CEO roles in start-ups and leadership at Guidant Corporation.

How might Maria Sainz’s election impact ATRI?

Her background in innovative medtech could strengthen ATRI's strategic direction and competitiveness.

What companies has Maria Sainz previously led?

She has served as CEO of multiple medtech start-ups, two of which were acquired by CooperSurgical and Stryker Corporation.

Atrion Corp

NASDAQ:ATRI

ATRI Rankings

ATRI Latest News

ATRI Stock Data

809.44M
1.35M
23.37%
71.86%
2.53%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
ALLEN